| General Comments | ||||
|---|---|---|---|---|
| Hematology | ||||
| Biochemical Investigation of Anemias and Iron Overload | ||||
| General Chemistry | ||||
| Muscle Enzymes | ||||
| Lipids | ||||
| Thyroid Function | ||||
| Reproductive and Gonadal | ||||
| Hours After Meal | ||||
| hours pc: 2.25 | ||||
| WBC | 7.9 | 4.0-10.0 | 10*9/L | |
| RBC | A | 6.11 | 4.20-5.40 | 10*12/L |
| Hemoglobin | A | 185 | 135-170 | g/L |
| Hematocrit | A | 0.54 | 0.40-0.50 | L/L |
| MCV | 89 | 82-98 | fl | |
| MCH | 30.3 | 27.5-33.5 | pg | |
| MCHC | 341 | 300-370 | g/L | |
| RDW | 13.8 | 11.5-14.5 | % | |
| Platelet Count | 269 | 150-400 | 10*9/L | |
| Differential | ||||
| Neutrophils | 5.4 | 2.0-7.5 | 10*9/L | |
| Lymphocytes | 1.2 | 1.0-4.0 | 10*9/L | |
| Monocytes | 0.8 | 0.1-0.8 | 10*9/L | |
| Eosinophils | 0.4 | 0.0-0.7 | 10*9/L | |
| Basophils | 0.1 | 0.0-0.2 | 10*9/L | |
| Granulocytes Immature | 0.0 | 0.0-0.1 | 10*9/L | |
| Ferritin | 86 | 24-444 | ug/L | |
| Adults >18 y: <15 ug/L: diagnostic of iron deficiency 15-30 ug/L: probable iron deficiency >30 ug/L: iron deficiency unlikely >100 ug/L: normal iron stores =>600 ug/L: consider test for iron overload See BC guideline for Iron Deficiency Diagnosis and Management, 2019 | ||||
| Glucose Random | Results are pending ... | |||
| Sodium | A | 132 | 135-145 | mmol/L |
| Potassium | 4.6 | 3.5-5.0 | mmol/L | |
| Creatinine | 72 | 45-110 | umol/L | |
| Estimated GFR | 94 | >=60 | ||
| Units for eGFR are mL/min/1.73sq.m Kidney function estimate based on assumption of a stable serum creatinine concentration: diet, drugs, pregnancy, clinical state and muscle mass can affect accuracy of the estimate. Urinary ACR may assist interpretation. See https://www2.gov.bc.ca/gov/content/ health/practitioner-professional- resources/bc-guidelines/chronic-kidney- disease | ||||
| Calcium | 2.42 | 2.10-2.60 | mmol/L | |
| Total Protein | 73 | 60-80 | g/L | |
| Albumin | 45 | 35-50 | g/L | |
| Total Bilirubin | 11 | <17 | umol/L | |
| Alkaline Phosphatase | 45 | 40-145 | U/L | |
| Gamma GT | 20 | <65 | U/L | |
| Alanine Aminotransferase | A | 65 | <50 | U/L |
| Creatine Kinase | A | 1977 | <165 | U/L |
| Cholesterol | 4.17 | 2.00-5.19 | mmol/L | |
| LDL Cholesterol | 2.73 | 1.50-3.40 | mmol/L | |
| The optimal LDL cholesterol level for intermediate and high risk individuals is <= 2.00 mmol/L. If triglycerides are => 1.50 mmol/L, consider monitoring of alternate lipid targets non HDL-cholest- erol or apoB. For low risk individuals with LDL cholesterol => 5.00 mmol/L, target reduction of LDL cholesterol => 50 percent. See Can J Cardiol 2013 vol 29 pgs 151 to 167. | ||||
| HDL Cholesterol | 1.03 | >0.99 | mmol/L | |
| Chol/HDL (Risk Ratio) | 4.05 | <4.9 | ||
| Non HDL Cholesterol | 3.14 | mmol/L | ||
| Non HDL-cholesterol is calculated from total cholesterol and HDL-C and is not affected by the fasting status of the patient. The optimal non HDL-cholesterol level for intermediate and high risk individuals is <= 2.60 mmol/L. See Can J Cardiol 2013 vol 29 pgs 151 to 167. | ||||
| Triglycerides | 0.91 | <2.21 | mmol/L | |
| TSH | 4.09 | 0.32-5.04 | mU/L | |
| Estradiol | 150 | <162 | pmol/L | |
| Testosterone | A | 36.2 | 8.4-28.8 | nmol/L |
